MedImmune Ventures
Venture Capital
MedImmune Ventures is a wholly owned venture capital fund within the AstraZeneca/MedImmune group of companies. It was created in 2002 to leverage MedImmune’s expertise in discovering, developing and commercializing biotechnology products, as...Founded in 1987
Homepage: http://medimmuneventures.com
HQ
20878 One MedImmune WayGaithersburg
USA MD
Phone: (301) 398-4624
MedImmune Ventures at CrunchBase
Joseph Amprey Senior Managing Director
Past
February, 2013
MedImmune Ventures invested $9M in Catabasis Pharmaceuticals as unattributed round
November, 2012
MedImmune Ventures invested $37.5M in Applied Genetics Technologies Corporation as a Series B round
MedImmune Ventures invested $50M in Ambit Biosciences as unattributed round
July, 2012
MedImmune Ventures invested $12M in Coferon as a Series B round
December, 2011
MedImmune Ventures invested $8M in Catabasis Pharmaceuticals as a Series A round
June, 2011
MedImmune Ventures invested $30M in Ambit Biosciences as a Series D round
June, 2010
MedImmune Ventures invested $15M in Corridor Pharmaceuticals as a Series A round
MedImmune Ventures invested $18M in Inotek Pharmaceuticals as a Series D round
April, 2010
MedImmune Ventures invested $39M in Catabasis Pharmaceuticals as a Series A round
January, 2010
MedImmune Ventures invested $51.6M in VentiRx Pharmaceuticals as a Series A round
November, 2009
MedImmune Ventures invested $30M in Virdante Pharmaceuticals as a Series A round
MedImmune Ventures invested $4.6M in Arginetix as a Series B round
June, 2009
MedImmune Ventures invested $30M in VaxInnate as a Series D round
MedImmune Ventures invested $11.8M in Applied Genetics Technologies Corporation as a Series C round
March, 2009
MedImmune Ventures invested $8M in NKT Therapeutics as a Series A round
January, 2009
MedImmune Ventures invested $25M in Rib-X Pharmaceuticals as unattributed round
MedImmune Ventures invested $22M in Hydra Biosciences as a Series D round
October, 2008
MedImmune Ventures invested $2.3M in Arginetix as angel investor
April, 2008
MedImmune Ventures invested $28M in LigoCyte Pharmaceuticals as a Series B round
March, 2008
MedImmune Ventures invested $30M in BrainCells as a Series B round
January, 2007
MedImmune Ventures invested $35M in Sequoia Pharmaceuticals as a Series C round
October, 2006
MedImmune Ventures invested $40M in VaxInnate as a Series C round
June, 2006
MedImmune Ventures invested $55M in VLST Corporation as a Series B round
May, 2006
MedImmune Ventures invested $43.8M in Avidia as a Series C round
May, 2005
MedImmune Ventures invested $28.5M in Avidia as a Series B round
November, 2003
MedImmune Ventures invested $27M in Applied Genetics Technologies Corporation as a Series B round
1987
MedImmune Ventures was founded in 1987